Product NDC: | 55390-106 |
Proprietary Name: | Allopurinol sodium |
Non Proprietary Name: | Allopurinol sodium |
Active Ingredient(s): | 500 mg/25mL & nbsp; Allopurinol sodium |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55390-106 |
Labeler Name: | Bedford Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076870 |
Marketing Category: | ANDA |
Start Marketing Date: | 20040901 |
Package NDC: | 55390-106-01 |
Package Description: | 1 VIAL in 1 BOX, UNIT-DOSE (55390-106-01) > 25 mL in 1 VIAL |
NDC Code | 55390-106-01 |
Proprietary Name | Allopurinol sodium |
Package Description | 1 VIAL in 1 BOX, UNIT-DOSE (55390-106-01) > 25 mL in 1 VIAL |
Product NDC | 55390-106 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Allopurinol sodium |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20040901 |
Marketing Category Name | ANDA |
Labeler Name | Bedford Laboratories |
Substance Name | ALLOPURINOL SODIUM |
Strength Number | 500 |
Strength Unit | mg/25mL |
Pharmaceutical Classes | Xanthine Oxidase Inhibitor [EPC],Xanthine Oxidase Inhibitors [MoA] |